Syra Health Corp. SYRA
0.71 USD -0.08 (-9.55%)
Nov 6, 2026, 11:57 AM EST
0.71 Day range 0.8033
0.06 52-week range 1.05
- YTD
- +725.58%
- 1 year
- +959.70%
Financial health
Altman Z-Score
5.31 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A4 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 3
- P/E 3
- P/B 2
Valuation
P/E -1.1×
FY 2020 5y median -1.7× FY 2025
P/S 0.1×
FY 2020 5y median 0.9× FY 2025
P/B 0.5×
FY 2020 5y median 1.0× FY 2025
P/FCF -2.3×
FY 2020 5y median -2.3× FY 2025
EV/EBITDA 0.5×
FY 2020 5y median -0.7× FY 2025
EV/Sales -0.1×
FY 2020 5y median 0.3× FY 2025
FCF Yield -43.9%
FY 2020 5y median -43.9% FY 2025
Profitability
Gross Margin 34.4%
FY 2020 5y median 25.5% FY 2025
Operating Margin -12.5%
FY 2020 5y median -37.2% FY 2025
Net Margin -12.4%
FY 2020 5y median -37.7% FY 2025
ROE -42.7%
FY 2020 5y median -73.2% FY 2025
ROIC -40.3%
FY 2020 5y median -67.8% FY 2025
ROA -32.3%
FY 2020 5y median -59.7% FY 2025
Growth (YoY)
Revenue -9.5%
FY 2020 FY 2025
Operating Income 76.0%
FY 2020 FY 2025
EPS (diluted) 85.5%
FY 2020 FY 2025
Free Cash Flow 84.8%
FY 2020 FY 2025
Financial Health
Current Ratio 4.1×
FY 2020 5y median 4.1× FY 2025
Quick Ratio 4.1×
FY 2020 5y median 4.1× FY 2025
Debt / Equity 0.1×
FY 2020 5y median 0.1× FY 2025
Net Debt / EBITDA 1.7×
FY 2020 5y median 0.5× FY 2025
Interest Coverage -68.1×
FY 2020 5y median -68.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31